Abstract
Circular RNAs (circRNAs) play vital roles in various types of cancer and chemosentivity. In the progression of carcinogenesis, exosomes are messengers for intercellular communication. The aim of this study was to explore the role of exosomal circRNA phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (circ_PIP5K1A) in non-small cell lung cancer (NSCLC) progression and cisplatin sensitivity. The expression levels of circ_PIP5K1A, miR-101 and ATP binding cassette subfamily C member 1 (ABCC1) were detected by quantitative real-time polymerase chain reaction or western blot assay. Cell Counting Kit-8 assay was used to detect cell viability and 50% inhibitory concentration value of cisplatin. Cell migration, invasion, proliferation, and apoptosis were determined by wound healing assay, transwell assay, colony formation assay, and flow cytometry, respectively. A xenograft tumor model was established to explore the role of circ_PIP5K1A in vivo. Exosomes were detected using transmission electron microscopy analysis. The interaction between miR-101 and circ_PIP5K1A or ABCC1 was predicted by bioinformatics analysis and verified by dual-luciferase reporter assay and RNA pull-down assay. Circ_PIP5K1A and ABCC1 were overexpressed and miR-101 was downregulated in NSCLC tissues, serum samples, and cells. Knockdown of exosomal circ_PIP5K1A inhibited NSCLC cell proliferation, migration, and invasion and promoted apoptosis and cisplatin sensitivity. Likewise, circ_PIP5K1A downregulation inhibited tumor growth. MiR-101 was a direct target of circ_PIP5K1A, and its knockdown reversed the effects of circ_PIP5K1A silence on inhibition of NSCLC progression and promotion of cisplatin sensitivity. Moreover, ABCC1 was a downstream target of miR-101, and miR-101 overexpression inhibited the progression of NSCLC cells and increased cisplatin sensitivity by targeting ABCC1. Besides, circ_PIP5K1A positively regulated ABCC1 expression by sponging miR-101. Exosomal circ_PIP5K1A knockdown inhibited NSCLC progression and promoted cisplatin sensitivity by regulating miR-101/ABCC1 axis, providing a novel avenue for treatment of NSCLC.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11010-021-04083-8/MediaObjects/11010_2021_4083_Fig8_HTML.png)
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29
Hirsch FR, Suda K, Wiens J, Bunn PA Jr (2016) New and emerging targeted treatments in advanced non-small-cell lung cancer. The Lancet 388(10048):1012–1024
Chang A (2011) Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 71(1):3–10
Geng Y, Jiang J, Wu C (2018) Function and clinical significance of circRNAs in solid tumors. J Hematol Oncol 11(1):98
Chen L-L, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12(4):381–388
Li X, Yang L, Chen LL (2018) The biogenesis, functions, and challenges of circular RNAs. Mol Cell 71(3):428–442. https://doi.org/10.1016/j.molcel.2018.06.034
Zhang Y, Xue W, Li X, Zhang J, Chen S, Zhang JL, Yang L, Chen LL (2016) The biogenesis of nascent circular RNAs. Cell Rep 15(3):611–624. https://doi.org/10.1016/j.celrep.2016.03.058
Cocucci E, Meldolesi J (2015) Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol 25(6):364–372
Kahlert C, Kalluri R (2013) Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med 91(4):431–437
Shang Q, Yang Z, Jia R, Ge S (2019) The novel roles of circRNAs in human cancer. Mol Cancer 18(1):6. https://doi.org/10.1186/s12943-018-0934-6
Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W, Wang G, Wu P, Wang H, Jiang L, Yuan W, Sun Z, Ming L (2019) Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer 18(1):116. https://doi.org/10.1186/s12943-019-1041-z
Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S, Yuan H (2018) Microarray profile of circular RNAs identifies hsa_circ_0014130 as a new circular RNA biomarker in non-small cell lung cancer. Sci Rep 8(1):2878. https://doi.org/10.1038/s41598-018-21300-5
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384–388. https://doi.org/10.1038/nature11993
Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ (2011) MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol 6(4):671–678. https://doi.org/10.1097/JTO.0b013e318208eb35
Munoz M, Henderson M, Haber M, Norris M (2007) Role of the MRP1/ABCC1 multidrug transporter protein in cancer. IUBMB Life 59(12):752–757. https://doi.org/10.1080/15216540701736285
Cao L, Chen J, Ou B, Liu C, Zou Y (2017) GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Biomed Pharmacother 93:570–579
Huang MS, Liu JY, Xia XB, Liu YZ, Li X, Yin JY, Peng JB, Wu L, Zhang W, Zhou HH, Liu ZQ (2019) Hsa_circ_0001946 inhibits lung cancer progression and mediates cisplatin sensitivity in non-small cell lung cancer via the nucleotide excision repair signaling pathway. Front Oncol 9:508. https://doi.org/10.3389/fonc.2019.00508
Yan Y, Fu G, Ye Y, Ming L (2017) Exosomes participate in the carcinogenesis and the malignant behavior of gastric cancer. Scand J Gastroenterol 52(5):499–504. https://doi.org/10.1080/00365521.2016.1278458
Ma Y, Cong X, Zhang Y, Yin X, Zhu Z, Xue Y (2020) CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis. Cancer Cell Int 20:81. https://doi.org/10.1186/s12935-020-1122-5
Sun Y, Li X, Chen A, Shi W, Wang L, Yi R, Qiu J (2019) circPIP5K1A serves as a competitive endogenous RNA contributing to ovarian cancer progression via regulation of miR-661/IGFBP5 signaling. J Cell Biochem 120(12):19406–19414. https://doi.org/10.1002/jcb.29055
Zhang Q, Zhang C, Ma JX, Ren H, Sun Y, Xu JZ (2019) Circular RNA PIP5K1A promotes colon cancer development through inhibiting miR-1273a. World J Gastroenterol 25(35):5300–5309. https://doi.org/10.3748/wjg.v25.i35.5300
Geng Y, Bao Y, Zhang W, Deng L, Su D, Zheng H (2020) Circular RNA hsa_circ_0014130 inhibits apoptosis in non-small cell lung cancer by sponging miR-136-5p and upregulating BCL2. Mol Cancer Res 18(5):748–756. https://doi.org/10.1158/1541-7786.mcr-19-0998
Chi Y, Luo Q, Song Y, Yang F, Wang Y, Jin M, Zhang D (2019) Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation. J Cell Biochem 120(11):19019–19030. https://doi.org/10.1002/jcb.29225
Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, Finn SP (2017) Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci 4:38. https://doi.org/10.3389/fmolb.2017.00038
Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V (2009) MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315(8):1439–1447. https://doi.org/10.1016/j.yexcr.2008.12.010
Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC, Pang X (2011) Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 4(7):1073–1083. https://doi.org/10.1158/1940-6207.capr-10-0333
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X, Wang M, Huang C, Wang L, Zeng F, Jiang G (2017) LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Cancer Lett 388:281–291. https://doi.org/10.1016/j.canlet.2016.12.005
Zhang X, He X, Liu Y, Zhang H, Chen H, Guo S, Liang Y (2017) MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1. Biomed Pharmacother 93:1065–1073. https://doi.org/10.1016/j.biopha.2017.07.005
Cho HM, Jeon HS, Lee SY, Jeong KJ, Park SY, Lee HY, Lee JU, Kim JH, Kwon SJ, Choi E, Na MJ, Kang J, Son JW (2011) microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med 2(5):963–967. https://doi.org/10.3892/etm.2011.284
Leslie EM, Haimeur A, Waalkes MP (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J Biol Chem 279(31):32700–32708. https://doi.org/10.1074/jbc.M404912200
Gao R, Fang C, Xu J, Tan H, Li P, Ma L (2019) LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145. Arch Biochem Biophys 663:183–191. https://doi.org/10.1016/j.abb.2019.01.005
Lu L, Ju F, Zhao H, Ma X (2015) MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1. Biotechnol Lett 37(12):2387–2394. https://doi.org/10.1007/s10529-015-1941-y
Pei K, Zhu JJ, Wang CE, Xie QL, Guo JY (2016) MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1. Eur Rev Med Pharmacol Sci 20(22):4697–4704
Acknowledgements
None.
Funding
This work was supported by Medical and Health Science and Technology Development Plan of Shandong province (NO:2016WS0415).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shao, N., Song, L. & Sun, X. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis. Mol Cell Biochem 476, 2253–2267 (2021). https://doi.org/10.1007/s11010-021-04083-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-021-04083-8